Cargando…

Efficacy and safety of intravenous immunoglobulins for the treatment of viral encephalitis: a systematic literature review

BACKGROUND: For most viral encephalitides, therapy is merely supportive. Intravenous immunoglobulins (IVIG) have been used as a prophylactic and therapeutic approach. We conduct a systematic review on the safety and efficacy of IVIG in viral encephalitis. METHODS: We conducted a systematic review as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wagner, Judith N., Leibetseder, Annette, Troescher, Anna, Panholzer, Juergen, von Oertzen, Tim J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782811/ https://www.ncbi.nlm.nih.gov/pubmed/33675421 http://dx.doi.org/10.1007/s00415-021-10494-w

Ejemplares similares

Patients with breakthrough tick‐borne encephalitis suffer a more severe clinical course and display extensive magnetic resonance imaging changes
por: Wagner, J. N., et al.
Publicado: (2020)

The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis
por: Lee, Soon‐Tae, et al.
Publicado: (2022)

Steroids for the treatment of viral encephalitis: a systematic literature review and meta-analysis
por: Hodzic, Emira, et al.
Publicado: (2023)

Spontaneous Intracerebral Hemorrhage Due to Delta Storage Pool Disease in a Patient on a Serotonin-Norepinephrine Reuptake Inhibitor
por: Leibetseder, Annette, et al.
Publicado: (2019)

Evaluation of Clinical and Paraclinical Findings for the Differential Diagnosis of Autoimmune and Infectious Encephalitis
por: Wagner, Judith N., et al.
Publicado: (2018)

Treatment of West Nile virus encephalitis with intravenous immunoglobulin.
por: Shimoni, Z, et al.
Publicado: (2001)

Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experience
por: Kinsella, JA, et al.
Publicado: (2018)

Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections
por: Perricone, Carlo, et al.
Publicado: (2021)

Efficacy and safety of intravenous immunoglobulin for treating refractory livedoid vasculopathy: a systematic review
por: Gao, Yimeng, et al.
Publicado: (2022)

Efficacy and safety of a new intravenous immunoglobulin (Panzyga(®)) in chronic immune thrombocytopenia
por: Arbach, O., et al.
Publicado: (2019)

Virus safety of intravenous immunoglobulin: Future challenges
por: Boschetti, Nicola, et al.
Publicado: (2005)

Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature
por: Leibetseder, Annette, et al.
Publicado: (2021)

Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin
por: Kim, Ahwon, et al.
Publicado: (2019)

346. Eastern Equine Encephalitis and Use of Intravenous Immunoglobulin Therapy and High-Dose Steroids
por: Collens, Sarah I, et al.
Publicado: (2020)

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
por: Han, Ji Whan
Publicado: (2017)

Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies
por: Perez, Elena E., et al.
Publicado: (2021)

Clinical Efficacy of Intravenous Immunoglobulins in Management of Toxic Shock Syndrome: An Updated Literature Review
por: Amreen, Sana, et al.
Publicado: (2021)

Efficacy and Safety of Intravenous Immunoglobulin Treatment in Selected Neurological Diseases—One Centre’s Experience Based on the Therapy of 141 Patients
por: Lasek-Bal, Anetta, et al.
Publicado: (2023)

Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments
por: Massa, Federico, et al.
Publicado: (2022)

Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial
por: Hill, Matilda, et al.
Publicado: (2023)

Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022)

Evidence for the Use of Intravenous Immunoglobulins—A Review of the Literature
por: Kivity, Shaye, et al.
Publicado: (2009)

A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal
por: Rayamajhi, Ajit, et al.
Publicado: (2015)

Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?
por: Li, Tao-Ran, et al.
Publicado: (2020)

Favorable Outcome with Intravenous Immunoglobulin Therapy in Late-Onset Anti-mGluR1 Encephalitis: A Case Report and Literature Review
por: Sakashita, Kento, et al.
Publicado: (2023)

Retracted: Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Healthcare Engineering, Journal of
Publicado: (2023)

Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency
por: Wasserman, Richard L., et al.
Publicado: (2012)

Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP)
por: Hong, Junshik, et al.
Publicado: (2018)

Efficacy and safety of human intravenous immunoglobulin 5% (Ig VENA) in pediatric patients affected by primary immunodeficiency
por: Ricci, Silvia, et al.
Publicado: (2020)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

Intravenous immunoglobulin therapy could have efficacy in severe sepsis
por: Kim, Ahmin, et al.
Publicado: (2013)

Correction: A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal
por: Rayamajhi, Ajit, et al.
Publicado: (2015)

HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute viral encephalitis
por: Tuttolomondo, Antonino, et al.
Publicado: (2018)

Efficacy and Safety of IQYMUNE®, a Ten Percent Intravenous Immunoglobulin in Adult Patients With Chronic, Primary Immune Thrombocytopenia
por: Rodeghiero, Francesco, et al.
Publicado: (2018)

Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial
por: Fukui, Saori, et al.
Publicado: (2021)

Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism
por: Connery, Kathleen, et al.
Publicado: (2018)

Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review
por: Focosi, Daniele, et al.
Publicado: (2022)

Ensuring Viral Safety of Equine Immunoglobulins during Production
por: Mashin, V. V., et al.
Publicado: (2022)

Encephalitis, Viral
por: Johnson, Richard T.
Publicado: (2003)

Encephalitis, Viral
por: Turtle, L., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nnabmgl7eba80rr03c54hvdnhk